@IndepthDiver (in reply to your post re Loihi above)
Totally agree mate. This is an article I posted yesterday, it is an interview with Pat Gelsinger. The commentary is largely relating to Intel being concerned about Architectural Advancement in Ai , but also Gelsinger states they are going to be bringing products into this space...........Gelsinger must have a solid CONFIRMED PLAN to be making these claims publicly imo there's no way he would otherwise he would look like a fool.
So what products are they possibly going to bring to market to compete in the Ai space KNOWING FULL WELL THAT -
1. Loihi is nowhere near ready (as you say why bother)
and
2. (and more importantly) AKIDA 1000 (working better than Loihi, cheap and available), 2000, 3000 are pretty much upon us................
Gelsingers confidence has to come from somewhere as it is clear Loihi is not the answer
Article:
https://www.crn.com/slide-shows/components-peripherals/pat-gelsinger-intel-will-be-more-ecosystem-friendly-than-nvidia
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-26162
-
-
- There are more pages in this discussion • 7,419 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $366.5M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $760.0K | 3.766M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
83 | 1416159 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 702532 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
82 | 1417085 | 0.195 |
62 | 1595021 | 0.190 |
31 | 1283131 | 0.185 |
53 | 1543743 | 0.180 |
17 | 632162 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 659084 | 24 |
0.205 | 956288 | 21 |
0.210 | 1587706 | 30 |
0.215 | 536730 | 24 |
0.220 | 758461 | 24 |
Last trade - 14.21pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online